Literature DB >> 24648013

Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.

Leona A Doyle1.   

Abstract

The 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone incorporates changes in tumor classification, as well as new genetic insights into the pathogenesis of many different tumor types that have emerged over the 11 years since the publication of the prior volume. This article reviews changes in the classification of soft tissue and bone sarcomas as well as tumors of intermediate biologic potential in the 2013 World Health Organization volume, new molecular insights into these tumors, and associated surgical and clinical implications.
© 2014 American Cancer Society.

Entities:  

Keywords:  World Health Organization; bone; sarcoma; soft tissue; tumor; tumor classification

Mesh:

Year:  2014        PMID: 24648013     DOI: 10.1002/cncr.28657

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  118 in total

1.  A case of mediastinum undifferentiated high grade pleomorphic sarcoma.

Authors:  Katsuhiro Okuda; Motoki Yano; Satoru Moriyama; Hiroshi Haneda; Tsutomu Tatematsu; Ayumi Suzuki; Risa Oda; Ryoichi Nakanishi
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Epithelioid hemangioma of bone: A unique case with multifocal metachronous bone lesions.

Authors:  Jie Xian; Alberto Righi; Daniel Vanel; Nicola Baldini; Costantino Errani
Journal:  J Clin Orthop Trauma       Date:  2019-03-16

Review 3.  Recent translational research into targeted therapy for liposarcoma.

Authors:  Rashi Bharat Patel; Ting Li; Zhichao Liao; Jivani Aakash Jaldeepbhai; H A Pavanika N V Perera; Sujani Kaushalya Muthukuda; Dholiya Hardeep Dhirubhai; Vaibhav Singh; Xiaoling Du; Jilong Yang
Journal:  Stem Cell Investig       Date:  2017-03-15

Review 4.  Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment.

Authors:  Ari Rosenberg; Mark Agulnik
Journal:  Curr Treat Options Oncol       Date:  2018-03-15

Review 5.  Epithelioid hemangioma of bone: a report of two special cases and a literature review.

Authors:  Qin Zhou; Liangji Lu; YanBiao Fu; KeWei Xiang; Leiming Xu
Journal:  Skeletal Radiol       Date:  2016-09-22       Impact factor: 2.199

6.  Primary Myxoid Liposarcoma of the Greater Omentum in a Rhesus Macaque (Macaca mulatta).

Authors:  Marie-Josee Mf Lemoy; Gregory W Salyards; Rebekah I Keesler; J R Reader
Journal:  Comp Med       Date:  2018-08-02       Impact factor: 0.982

7.  [Treatment of retroperitoneal sarcoma in Germany : Results of a survey of the German Society of General and Visceral Surgery, the German Interdisciplinary Sarcoma Study Group and the advocacy group Das Lebenshaus].

Authors:  J Jakob; A Gerres; U Ronellenfitsch; L Pilz; M Wartenberg; B Kasper; H-R Raab; P Hohenberger
Journal:  Chirurg       Date:  2018-01       Impact factor: 0.955

8.  Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.

Authors:  Naser M Ali; Stefania Niada; Anna T Brini; Mark R Morris; Sathishkumar Kurusamy; Abdullah Alholle; David Huen; Cristina R Antonescu; Franck Tirode; Vaiyapuri Sumathi; Farida Latif
Journal:  J Pathol       Date:  2018-12-27       Impact factor: 7.996

9.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas.

Authors:  Hiromasa Yamamoto; Kei Namba; Haruchika Yamamoto; Tomohiro Toji; Junichi Soh; Kazuhiko Shien; Ken Suzawa; Takeshi Kurosaki; Shinji Otani; Mikio Okazaki; Seiichiro Sugimoto; Masaomi Yamane; Katsuhito Takahashi; Toshiyuki Kunisada; Takahiro Oto; Shinichi Toyooka
Journal:  Surg Today       Date:  2020-08-03       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.